Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD Jul 12, 2021
COMPASS Pathways Teams with UK Institutions to Research Innovations in Mental Health Care Jul 7, 2021
Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence Jul 6, 2021
The Latest On Psybio Therapeutics: CEO Evan Levine Comments On Maxim Group Buy Rating, European Research, And More Jul 6, 2021
COMPASS Pathways joins forces with King’s College London and South London and Maudsley NHS Foundation Trust to… Jul 5, 2021